Cardiovascular risk factors and cognitive decline in adults aged 50 and over: a population-based cohort study
The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: the objective of the present study was to explore the association between cardiovascular risk and cognitive decline in adults aged 50 and over. METHODS: participants were older adults who participated in the English Longitudinal Study of Ageing. Outcome measures included standardised z-scores for global cognition, memory and executive functioning. Associations between cardiovascular risk factors and 10-year Framingham risk scores with cognitive outcomes at 4-year and 8-year follow-ups were estimated. RESULTS: the mean age of participants (n = 8,780) at 2004-05 survey was 66.93 and 55% were females. Participants in the highest quartile of Framingham stroke risk score (FSR) had lower global cognition (b = -0.73,CI: -1.37, -0.10), memory (b = -0.56, CI: -0.99, -0.12) and executive (b = -0.37, CI: -0.74, -0.01) scores at 4-year follow-up compared with those in the lower quartile. Systolic blood pressure ≥160 mmHg at 1998-2001 survey was associated with lower global cognitive (b = -1.26, CI: -2.52, -0.01) and specific memory (b = -1.16, CI: -1.94, -0.37) scores at 8-year follow-up. Smoking was consistently associated with lower performance on all three cognitive outcomes. CONCLUSION: elevated cardiovascular risk may be associated with accelerated decline in cognitive functioning in the elderly. Future intervention studies may be better focused on overall risk rather than individual risk factor levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These tests have been shown to have high validity and reliability in the studies of others [16–18].”
From Digital exclusion and cognitive impairment in older people: findings from five longitudinal studies (2024) · cites this paper as [17]
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267 · cited 1×
“An abbreviated Center for Epidemiological Studies Depression Scale (CES-D) [20] measure was used to create a continuous measure of depressive symptoms (scores ranged from 0 to 8).”
MethodCardiovascular disease risk profiles
Anderson, K. M., Odell, P. M., Wilson, P. W. F., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90861-b · Cited by 2,163 · cited 1×
“[19].”
Lithell, H., Hansson, L., Skoog, I., Elmfeldt, D., Hofman, A., Olofsson, B., Trenkwalder, P., & Zanchetti, A. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00011 · Cited by 1,409 · cited 1×
“The limited evidence of an association between BP and cognitive decline at 4 year may explain the lack of significant effect of short-term antihypertensive clinical trials with cognitive decline [24–26].”
BackgroundSmoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies
Anstey, K. J., von Sanden, C., Salim, A., & O'Kearney, R. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm116 · Cited by 921 · cited 1×
“There is more consistent evidence that smokers tend to be at a greater risk of cognitive decline compared with nonsmokers [11] although the risk might be limited to specific cognitive domains [9, 12].”
BackgroundThe Framingham Offspring Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Kompendium der Lipid-Studien · doi:10.1007/978-3-642-95642-3_25 · Cited by 831
Midlife and Late-Life Obesity and the Risk of Dementia: Cardiovascular Health Study
Fitzpatrick, A. L., Kuller, L. H., Lopez, O. L., Diehr, P., O’Meara, E. S., Longstreth, W. T., & Luchsinger, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.582 · Cited by 796
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline
Debette, S., Seshadri, S., Beiser, A., Au, R., Himali, J. J., Palumbo, C., Wolf, P. A., & DeCarli, C. (2011) · Neurology · doi:10.1212/wnl.0b013e318227b227 · Cited by 772 · cited 13×
“The primary analysis involved multivariable regression analysis using 2004–05 data to estimate the association of SBP, DBP, TC, smoking and BMI values with overall and specific cognitive decline at 4-year followup (2008–09 survey) adjusting for baseline (2004–05) covariates.”
BackgroundResultInfluentialMidlife vascular risk factors and late-life mild cognitive impairment: A population-based study
Kivipelto, M., Helkala, E.-L., Hänninen, T., Laakso, M. P., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · Neurology · doi:10.1212/wnl.56.12.1683 · Cited by 717
Hypertension Is Related to Cognitive Impairment: A 20-Year Follow-up of 999 Men
Kilander, L., Nyman, H., Boberg, M., Hansson, L., & Lithell, H. (1998) · Hypertension · doi:10.1161/01.hyp.31.3.780 · Cited by 630
Haan, M. N. (1999) · JAMA · doi:10.1001/jama.282.1.40 · Cited by 457 · cited 1×
“Present findings corroborate with earlier evidence that the negative association of BP with cognitive functioning represents a gradual process that takes place over long periods of time [4, 22, 23].”
ResultSerum Lipoprotein Levels, Statin Use, and Cognitive Function in Older Women
Yaffe, K., Barrett-Connor, E., Lin, F., & Grady, D. (2002) · Archives of Neurology · doi:10.1001/archneur.59.3.378 · Cited by 439
Measures of Cognitive Functioning in the AHEAD Study
Herzog, A. R., & Wallace, R. B. (1997) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/52b.special_issue.37 · Cited by 404
Prince, M. J., Bird, A. S., Blizard, R. A., & Mann, A. H. (1996) · BMJ · doi:10.1136/bmj.312.7034.801 · Cited by 317 · cited 1×
“The limited evidence of an association between BP and cognitive decline at 4 year may explain the lack of significant effect of short-term antihypertensive clinical trials with cognitive decline [24–26].”
BackgroundSerum cholesterol changes after midlife and late-life cognition: Twenty-one-year follow-up study
Solomon, A., Kåreholt, I., Ngandu, T., Winblad, B., Nissinen, A., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2007) · Neurology · doi:10.1212/01.wnl.0000256368.57375.b7 · Cited by 311 · cited 1×
“Longitudinal studies that explored the association of vascular risk factors with cognitive functioning produced contradictory or inconclusive findings reporting positive, negative and absent relationships between BP [1, 3–5], serum cholesterol [1, 6–8] and BMI [9, 10] with cognitive functioning.”
ResultCurrent and Remote Blood Pressure and Cognitive Decline
Glynn, R. J. (1999) · JAMA · doi:10.1001/jama.281.5.438 · Cited by 270 · cited 1×
“Longitudinal studies that explored the association of vascular risk factors with cognitive functioning produced contradictory or inconclusive findings reporting positive, negative and absent relationships between BP [1, 3–5], serum cholesterol [1, 6–8] and BMI [9, 10] with cognitive functioning.”
ResultStroke risk profile, brain volume, and cognitive function: The Framingham Offspring Study
Seshadri, S., Wolf, P. A., Beiser, A., Elias, M. F., Au, R., Kase, C. S., D’Agostino, R. B., & DeCarli, C. (2004) · Neurology · doi:10.1212/01.wnl.0000142968.22691.70 · Cited by 230 · cited 2×
“Finally, the study findings extend previous cross-sectional [13] studies and confirm longitudinal evidence [14] for a negative association between FSR and FCVDR risk scores with cognitive impairment in adults.”
BackgroundResultCigarette Smoking and Cognitive Decline in Midlife: Evidence From a Prospective Birth Cohort Study
Richards, M., Jarvis, M. J., Thompson, N., & Wadsworth, M. E. J. (2003) · American Journal of Public Health · doi:10.2105/ajph.93.6.994 · Cited by 204
Applegate, W. B. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420190047006 · Cited by 193 · cited 1×
“The limited evidence of an association between BP and cognitive decline at 4 year may explain the lack of significant effect of short-term antihypertensive clinical trials with cognitive decline [24–26].”
BackgroundBlood Pressure-Related Cognitive Decline: Does Age Make a Difference?
Elias, P. K., Elias, M. F., Robbins, M. A., & Budge, M. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000145858.07252.99 · Cited by 179 · cited 1×
“Present findings corroborate with earlier evidence that the negative association of BP with cognitive functioning represents a gradual process that takes place over long periods of time [4, 22, 23].”
ResultSmoking History and Cognitive Function in Middle Age From the Whitehall II Study
Sabia, S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.11.1165 · Cited by 128 · cited 1×
“There is more consistent evidence that smokers tend to be at a greater risk of cognitive decline compared with nonsmokers [11] although the risk might be limited to specific cognitive domains [9, 12].”
BackgroundImpact of cardiovascular risk factors on cognitive function: The Tromsø study
Arntzen, K. A., Schirmer, H., Wilsgaard, T., & Mathiesen, E. B. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03263.x · Cited by 119 · cited 1×
“Several cardiovascular (CVD) risk factors, including high blood pressure (BP), dyslipidaemia, smoking and obesity, have been proposed as important modifiable risk factors for cognitive decline [1, 2].”
BackgroundKaffashian, S., Dugravot, A., Nabi, H., Batty, G. D., Brunner, E., Kivimäki, M., & Singh-Manoux, A. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr133 · Cited by 108
Framingham Stroke Risk Profile and poor cognitive function: a population-based study
Llewellyn, D. J., Lang, I. A., Xie, J., Huppert, F. A., Melzer, D., & Langa, K. M. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-12 · Cited by 90 · cited 2×
“Finally, the study findings extend previous cross-sectional [13] studies and confirm longitudinal evidence [14] for a negative association between FSR and FCVDR risk scores with cognitive impairment in adults.”
BackgroundResultTotal cholesterol and oxysterols: Early markers for cognitive decline in elderly?
van den Kommer, T. N., Dik, M. G., Comijs, H. C., Fassbender, K. C., Lütjohann, D., & Jonker, C. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.005 · Cited by 89
Predictive Value of Mild Cognitive Impairment for Dementia
Baars, M. A. E., van Boxtel, M. P. J., Dijkstra, J. B., Visser, P. J., van den Akker, M., Verhey, F. R. J., & Jolles, J. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000200465 · Cited by 87
Vascular factors and prevention of dementia
Stephan, B. C. M., & Brayne, C. (2008) · International Review of Psychiatry · doi:10.1080/09540260802094456 · Cited by 42 · cited 1×
“Several cardiovascular (CVD) risk factors, including high blood pressure (BP), dyslipidaemia, smoking and obesity, have been proposed as important modifiable risk factors for cognitive decline [1, 2].”
Background
Research works printed but not linked: 2
- Scholes, 2008, Technical Report (wave 2): Retirement, Health and Relationships of the Older Population in England: the 2004 English Longitudinal Study of Ageing
- Goldberg, 1978, Manual of the General Health Questionnaire
Cited by
Iadecola, C., Yaffe, K., Biller, J., Bratzke, L. C., Faraci, F. M., Gorelick, P. B., Gulati, M., Kamel, H., Knopman, D. S., Launer, L. J., et al. (2016) · Hypertension · doi:10.1161/hyp.0000000000000053 · Cited by 746
“Further findings showed that having an SBP ≥160 mm Hg was associated with worse performance on the global and memory cognitive indexes 8 years later compared with having an SBP 140 mm Hg.124 The ARIC study95 showed that having hypertension at baseline, defined as SBP/DBP ≥140/90 mm Hg or taking antihypertensive medica…”
InfluentialAssociation between sleep duration and cognitive decline
Ma, Y., Liang, L., Zheng, F., Shi, L., Zhong, B., & Xie, W. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13573 · Cited by 535
Santos, C. Y., Snyder, P. J., Wu, W., Zhang, M., Echeverria, A., & Alber, J. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.005 · Cited by 431
“[41] Dregan A, Stewart R, Gulliford MC.”
A major role for cardiovascular burden in age-related cognitive decline
Qiu, C., & Fratiglioni, L. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.223 · Cited by 398
HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing
Zheng, F., Yan, L., Yang, Z., Zhong, B., & Xie, W. (2018) · Diabetologia · doi:10.1007/s00125-017-4541-7 · Cited by 280
“The task is well documented to be both reliable and valid, and has previously been used as an indicator of executive function for the ELSA population [18].”
Method
Metadata
- Authors
- Dregan, A., Stewart, R., & Gulliford, M. C.
- Affiliations
- King's College London (GB)
- Corresponding author
- Dregan, Alex
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-11-25
- Volume
- 42
- Issue
- 3
- Pages
- 338-345
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- OpenAlex
- W2129870994
- Cited by
- 195
- References
- 27
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 23 · 2023: 7 · 2022: 10 · 2021: 24 · 2020: 17 · 2019: 14 · 2018: 17 · 2017: 14 · 2016: 15 · 2015: 11 · 2014: 10 · 2013: 7 · 2012: 3
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Age and Ageing (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- cardiovascular risk factors, cognitive decline, older adults, Framingham Stroke Risk Score, systolic blood pressure, smoking, memory, executive function, global cognition, English Longitudinal Study of Ageing
- MeSH terms
- Age Factors, Aging, Blood Pressure, Cardiovascular Diseases, Cholesterol, Cognition, Cognition Disorders, England, Humans, Hypercholesterolemia, Hypertension, Longitudinal Studies, Memory, Middle Aged, Neuropsychological Tests, Obesity, Prospective Studies, Risk Factors, Smoking, Systole, Time Factors, Biomarkers, Body Mass Index, Multivariate Analysis, Linear Models, Executive Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.